Advertisement

Topics

The Norwegian Radium Hospital Research Foundation Company Profile

03:23 EST 12th December 2018 | BioPortfolio

The Norwegian Radium Hospital Research Foundation (RF) is an independent organisation founded in 1986 by The Norwegian Radium Hospital and the Norwegian Ministry of Health. Through commercialization of the expertise and research results from the NRH we will:- enhance the quality and the quantity of cancer research
- encourage business development
- establish and strengthen the relations to business and industry

RF serves as the Office of Technology Transfer (OTT) for the NRH by identifying and promoting research projects and innovations with commercial potential. Protection of intellectual property rights (IPR) falls within the scope of these activities. Our potential partner’s objectives, needs and desires in relation to NRH’s expectations will be focus for the initial discussions, which may lead to a license agreement or the establishment of a new company.

Location

Montebello
Oslo
0310
Norway

Contact

Phone: 47 22 93 57 64
Fax: 47 22 50 09 42
Email: je@radforsk.no


News Articles [1857 Associated News Articles listed on BioPortfolio]

The Norwegian Radium Hospital Research Foundation Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryThe Norwegian Radium Hospital Research Foundation Radium Hospital is a research center that conducts research programs and clinical studies. The center invests in oncology, novel therapeutics a...

The Norwegian Radium Hospital Research Foundation Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryThe Norwegian Radium Hospital Research Foundation RF is a healthcare research hospital that provides clinical studies. The hospital conducts research programs and clinical studies. It offers se...

Restriction of Radium-223 Dichloride Recommended in Europe

Use of the novel radiopharmaceutical radium-223 dichloride (Xofigo, Bayer) in prostate cancer should be restricted, according to the European Medicines Agency. News Alerts

Enzalutamide/Radium-223 Combo Shows Tolerability in mCRPC

Benjamin L. Maughn, MD, PharmD, discusses the tolerability of combining radium-223 dichloride and enzalutamide, as well as the next steps with this combination.

Details of Study That Led to Radium-223 Restriction in Europe

Details of the study that led to the restriction of the indication for the radiopharmaceutical radium-223 in prostate cancer have now been reported, and that restriction is questioned. Medscape Med...

Moving Radium-223 Forward in the Treatment Timeline for Prostate Cancer With Bone Metastases

Moving radium-223 (Xofigo) up in the treatment paradigm for patients with prostate cancer could provide better outcomes and longer survival, according to Richard G. Stock, MD. 

How Minnesotans handled leprosy around the turn of the 20th Century

In 1888, Dr. Gerhard Armauer Hansen, a Norwegian physician, arrived in St. Paul to study leprosy because of the high number of Norwegian immigrants in the state.

A novel research partnership in AI to advance drug discovery, longevity and aging research

(Biogerontology Research Foundation) Biogerontology Research Foundation CSO to collaborate with Insilico Medicine and WuXi AppTec on a research study in artificial intelligence for drug discovery. The...

PubMed Articles [2459 Associated PubMed Articles listed on BioPortfolio]

Radium isotopes-suspended sediment relationships in a muddy river.

Radium isotopes are known to be excellent geochemical tracers for study of oceanographic processes. We show here that radium isotopes can also be used to assess adsorption/desorption and transport pro...

Modified Calix4crowns as Molecular Receptors for Barium.

Invited for this month's cover picture is the group around Dr. Constantin Mamat at the Institute of Radiopharmaceutical Cancer Research at the Helmholtz-Zentrum Dresden-Rossendorf (Germany) together w...

Is There a Flare Phenomenon on Bone Scintigraphy in Men With Advanced Prostate Cancer Treated With Radium-223?

Radium-223 is an approved survival-prolonging treatment option in men with castration-resistant prostate cancer (mCRPC) and bone metastases. In the registration trial (ALSYMPCA), no regular imaging wa...

An improved method for radium-isotopes quartet determination by alpha-particle spectrometry by using Ra (Th) as isotopic tracer.

A new method for the determination of radium quartet (Ra) in environmental samples by alpha-particle spectrometry with PIPS detectors is described. This uses Ra as yield tracer, in equilibrium at the ...

Selective separation of radium and actinium from bulk thorium target material on strong acid cation exchange resin from sulfate media.

This work presents a complete scheme for the selective separation of actinium and radium isotopes from bulk Th target material, in a process that may be applied in a separation scheme for the producti...

Clinical Trials [4110 Associated Clinical Trials listed on BioPortfolio]

Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC

This research study is studying the safety and tolerability of an investigational combination of drugs, radium-223 plus pembrolizumab as a possible treatment for castration-resistant prost...

A Phase II Clinical Trial of Radium-223 Activity in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) With Asymptomatic Progression While on Abiraterone Acetate or Enzalutamide Besides AR-V7 Mutational Status (EXCAAPE)

Radium-223 is indicated for the treatment of patients with mCRPC with symptomatic bone metastases and no known visceral metastatic disease. However, very few data have been reported in pat...

Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

This is a prospective biomarker study on prostate cancer patients receiving Radium 223 as standard of care. Participants will take part in this research study because they have chosen Rad...

Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With Metastatic Castrate Resistant Prostate Cancer

More than 90% of patients with metastatic castration-resistant prostate cancer (mCRPC) no longer responding to androgen deprivation hormonal therapy have evidence of bone metastases. This ...

The Norwegian Acute Stroke Prehospital Project

The main aim of the NASPP study is to assess the efficacy and safety of the prehospital diagnosis of stroke using the Norwegian stroke ambulance concept. NASPP aims to demonstrate that ane...

Companies [3703 Associated Companies listed on BioPortfolio]

The Norwegian Radium Hospital Research Foundation

The Norwegian Radium Hospital Research Foundation (RF) is an independent organisation founded in 1986 by The Norwegian Radium Hospital and the Norwegian Ministry of Health. Through commercialization o...

Ultimovacs AS

Ultimovacs AS ('Ultimovacs') was established by Inven2 in 2011. The company's goal is to develop technology from the Norwegian Radium Hospital for use in cancer treatment and to m...

Nextera Communications

Nextera is a privately owned Norwegian biotech company. Our approach is to manipulate the disease at the initiation of the escalating immune cascade by identifying and subsequentl...

SINTEF

The SINTEF Group is the largest independent research organisation in Scandinavia. Every year, SINTEF supports the development of 2000 or so Norwegian and overseas companies via our research and develo...

NORSK INDUSTRI

On 28. November 2005 the new organisation Federation of Norwegian Industries was established. The new Federation will be formally operative as of 1. January 2006. From the start, the Federation of Nor...

More Information about "The Norwegian Radium Hospital Research Foundation" on BioPortfolio

We have published hundreds of The Norwegian Radium Hospital Research Foundation news stories on BioPortfolio along with dozens of The Norwegian Radium Hospital Research Foundation Clinical Trials and PubMed Articles about The Norwegian Radium Hospital Research Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Norwegian Radium Hospital Research Foundation Companies in our database. You can also find out about relevant The Norwegian Radium Hospital Research Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record